---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-26-034837"
form_type: "8-K"
ticker: "CODX"
cik: "0001692415"
company_name: "Co-Diagnostics, Inc."
filed_at: "2026-07-27T21:05:36+00:00"
generated_at: "2026-07-27T21:08:27.324128+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Co-Diagnostics removes $10M cap on ATM equity offering with Maxim Group

## Summary
- Amendment to equity distribution agreement removes fixed $10M aggregate limit on common stock sales.
- Future sales limited only by registered shares available under effective S-3 registration statement.
- Company extends standstill period with prior investors to August 14, 2026, restricting further equity issuances.
- Sales will be made through Maxim Group as agent under new prospectus supplement filed July 27, 2026.

## SEC filing metadata
- accession: 0001493152-26-034837
- form_type: 8-K
- ticker: CODX
- cik: 0001692415
- company_name: Co-Diagnostics, Inc.
- filed_at: 2026-07-27T21:05:36+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 1.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1692415/000149315226034837/0001493152-26-034837-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1692415/000149315226034837/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-26-034837
- JSON: https://secwatch.observer/filing/0001493152-26-034837.json
- Plain text: https://secwatch.observer/filing/0001493152-26-034837.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.